1. Home
  2. KE vs REPL Comparison

KE vs REPL Comparison

Compare KE & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KE
  • REPL
  • Stock Information
  • Founded
  • KE 1961
  • REPL 2015
  • Country
  • KE United States
  • REPL United States
  • Employees
  • KE N/A
  • REPL N/A
  • Industry
  • KE Electrical Products
  • REPL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KE Technology
  • REPL Health Care
  • Exchange
  • KE Nasdaq
  • REPL Nasdaq
  • Market Cap
  • KE 459.3M
  • REPL 547.0M
  • IPO Year
  • KE N/A
  • REPL 2018
  • Fundamental
  • Price
  • KE $27.88
  • REPL $9.45
  • Analyst Decision
  • KE Strong Buy
  • REPL Buy
  • Analyst Count
  • KE 1
  • REPL 9
  • Target Price
  • KE $28.00
  • REPL $12.00
  • AVG Volume (30 Days)
  • KE 176.0K
  • REPL 8.7M
  • Earning Date
  • KE 11-05-2025
  • REPL 11-06-2025
  • Dividend Yield
  • KE N/A
  • REPL N/A
  • EPS Growth
  • KE 91.88
  • REPL N/A
  • EPS
  • KE 0.96
  • REPL N/A
  • Revenue
  • KE $1,478,074,000.00
  • REPL N/A
  • Revenue This Year
  • KE N/A
  • REPL N/A
  • Revenue Next Year
  • KE $4.02
  • REPL N/A
  • P/E Ratio
  • KE $29.06
  • REPL N/A
  • Revenue Growth
  • KE N/A
  • REPL N/A
  • 52 Week Low
  • KE $12.41
  • REPL $2.68
  • 52 Week High
  • KE $33.19
  • REPL $17.00
  • Technical
  • Relative Strength Index (RSI)
  • KE 44.00
  • REPL 61.61
  • Support Level
  • KE $26.30
  • REPL $7.99
  • Resistance Level
  • KE $30.72
  • REPL $10.85
  • Average True Range (ATR)
  • KE 1.23
  • REPL 0.72
  • MACD
  • KE -0.17
  • REPL -0.15
  • Stochastic Oscillator
  • KE 36.21
  • REPL 36.13

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: